Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Omega-3 and Nano-Curcumin Effects on Vascular Cell Adhesion Molecule (Vcam) in Episodic Migraine Patients: A Randomized Clinical Trial Publisher Pubmed



Abdolahi M1 ; Karimi E2 ; Sarraf P3, 4 ; Tafakhori A3, 4 ; Siri G5 ; Salehinia F5 ; Sedighiyan M6 ; Asanjarani B5 ; Badeli M7 ; Abdollahi H8 ; Yoosefi N9 ; Yousefi A8 ; Rad AS6 ; Djalali M6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Amir Alam Hospital Complexes, Tehran University of Medical Sciences, Sa’adi Street, Tehran, Iran
  2. 2. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Poursina Street, Tehran, Iran
  3. 3. Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Internal Medicine, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Poursina Street, PO Box: 14155-6446, Tehran, Iran
  7. 7. Department of Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Poursina Street, Tehran, Iran
  8. 8. Department of Anesthesiology, Amir Alam Hospital Complexes, Tehran University of Medical Sciences, Sa’adi Street, Tehran, Iran
  9. 9. Honours Cellular Anatomical Physiology, University of British Columbia, Vancouver, BC, Canada

Source: BMC Research Notes Published:2021


Abstract

Objective: The purpose of this clinical trial was to examine the effect of omega-3 fatty acids (W-3 FAs), nanocurcumin and their combination on serum levels and gene expression of VCAM in patients with episodic migraine. Results: In this study, 80 patients were randomly divided in to 4 groups to receive for 2 months. Both serum levels and gene expression of VCAM showed remarkable decreases after single W-3 and after combined W-3 and nanocurcumin interventions. However, a borderline significant change and no remarkable change were observed after single nanocurcumin supplementation and in control group, respectively. While a significant difference between study groups in VCAM concentrations existed, there was no meaningful difference in VCAM gene expression among groups. It appears that the W-3 and combined W-3 and nanocurcumin can relieve VCAM serum level and its gene expression in patients with episodic migraine. Moreover, the combination of W-3 with nanocurcumin might cause more significant declines in VCAM level in the serum of migraine patients than when W-3 is administered alone. Trial Registration: This study was registered in Iranian Registry of Clinical Trials (IRCT) with ID number: NCT02532023. © 2021, The Author(s).
Experts (# of related papers)
Other Related Docs
16. Dietary Supplementation in Migraine: A Focus on Omega-3 Fatty Acids, Treatments# Nutraceuticals# Supplements# and Herbal Medicine in Neurological Disorders (2023)